Long COVID and Azithromycin: What the Peer-Reviewed Data Actually Shows—and What It Doesn't
Thousands of long COVID patients have turned to azithromycin in search of relief, sharing testimonials online that describe dramatic symptom improvements. Yet the peer-reviewed evidence remains far more measured, and medical authorities have stopped well short of endorsing this approach. Understanding the gap between patient experience and clinical proof is essential for anyone considering this path.